The hyperlink to a bill draft that precedes a summary contains the most recent version (Introduced/GA/Enacted) of the bill. If the session has ended, the hyperlink contains the latest version of the bill at the time of sine die adjournment. Note that the summary pertains to the bill as introduced, which is often different from the most recent version.
SB 136/CI/LM (BR 1420) - W. Westerfield
AN ACT relating to controlled substances.
Amend KRS 218A.020. 218A.070, and 218A.090 to classify all hydrocodone products as Schedule II controlled substances; amend KRS 314.011 relating to advanced practice registered nurses and KRS 320.210 and 320.240 relating to optometrists to preserve their existing prescriptive authority relative to hydrocodone-based products; amend KRS 218A.1430 to increase penalties for possession of, and trafficking in, synthetic drugs.
SB 136 - AMENDMENTS
SCS1/CI/LM - Clarify prescriptive authority for optometrists and advance practice registered nurses; add synthetic opioids, W-18 and W-15, to Schedule I; define "kratom" and add kratom to schedule I; amend various sections to conform.
Jan 28, 2016 - introduced in Senate
Feb 01, 2016 - to Judiciary (S)
Feb 11, 2016 - reported favorably, 1st reading, to Calendar with Committee Substitute (1)
Feb 12, 2016 - 2nd reading, to Rules
Feb 17, 2016 - posted for passage in the Regular Orders of the Day for Thursday, February 18, 2016
Feb 18, 2016 - 3rd reading, passed 35-1-1 with Committee Substitute (1)
Feb 19, 2016 - received in House
Feb 22, 2016 - to Judiciary (H)
Mar 14, 2016 - posted in committee